Health
Fear of new virus variant pushes U.S. toward more genomic sequencing – MarketWatch
The CDC said this week that the new B.1.1.7 strain may become the most dominant form of the virus in the U.S. by March
The United Kingdoms use of genomic sequencing to identify a more infectious strain of SARS-CoV-2 has largely served as a wake-up call for inadequate use of the technology in the U.S. Up until mid-December, the U.S. had sequenced about 0.3% of its COVID-19 samples, a percentage that is significantly lower than other developed countries despite the fact that it has one-fourth of the worlds cases. In comparison, the U.K. is sequencing about 10% of its samples, and Australia aims to real-time sequence…
Continue Reading
